Pierre‐Marie Morice
- Oncology top 10%
- PARP inhibition in cancer therapy 6
- Cancer Treatment and Pharmacology 2
- Reproductive Medicine top 10%
-
- DNA Repair Mechanisms 2
- CRISPR and Genetic Engineering 2
-
- Chronic Lymphocytic Leukemia Research 2
- Virus-based gene therapy research 1
-
- Pharmacovigilance and Adverse Drug Reactions 1
-
- SARS-CoV-2 and COVID-19 Research 1
- Co-authors
- Joachim AlexandreCharles DolladilleLaurent PoulainIsabelle Ray‐CoquardKathleen N. MooreBasile ChrétienEileen M. O’ReillyAlexandra Léary
- Journals
- SHILAP Revista de lepidopterología (1 paper)Annals of Neurology (1 paper)European Heart Journal (1 paper)
- Partner nations
- FranceUnited StatesSpain
In The Last Decade
Pierre‐Marie Morice
18 papers receiving 378 citations
Peers
Comparison fields: 5 of 51
- Oncology 243
- Reproductive Medicine 62
- Cardiology and Cardiovascular Medicine 81
- Hematology 35
- Cancer Research 44
Countries citing papers authored by Pierre‐Marie Morice
This map shows the geographic impact of Pierre‐Marie Morice's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre‐Marie Morice with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre‐Marie Morice more than expected).
Fields of papers citing papers by Pierre‐Marie Morice
This network shows the impact of papers produced by Pierre‐Marie Morice. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre‐Marie Morice. The network helps show where Pierre‐Marie Morice may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Pierre‐Marie Morice, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 2 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 0 | |
| 6 | 2023 | 10 | |
| 7 | 2023 | 4 | |
| 8 | 2022 | 1 | |
| 9 | 2022 | 4 | |
| 10 | 2022 | 7 | |
| 11 | 2022 | 4 | |
| 12 | 2021 | 32 | |
| 13 | 2021 | 6 | |
| 14 | 2021 | 18 | |
| 15 | 2021 | 127 | |
| 16 | 2020 | 153 | |
| 17 | 2017 | 0 | |
| 18 | [History of sterility in ancient times. I. Sterility in Egypt. Diagnostic recipes for sterility and pregnancy in ancient Egypt]. | 1995 | 1 |
| 19 | [Gelatinous transformation of the bone marrow in anorexia nervosa]. | 1995 | 2 |
| 20 | [Gynecology and obstetrics in ancient Egypt]. | 1994 | 5 |
About Pierre‐Marie Morice
Pierre‐Marie Morice is a scholar working on Oncology, Toxicology and Geriatrics and Gerontology, having authored 21 papers that have together received 382 indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (6 papers), DNA Repair Mechanisms (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), Cancer Treatment and Pharmacology (2 papers), CRISPR and Genetic Engineering (2 papers), Pharmacovigilance and Adverse Drug Reactions (1 paper), SARS-CoV-2 and COVID-19 Research (1 paper) and Virus-based gene therapy research (1 paper). The work is most often cited by research in Oncology (243 citations), Reproductive Medicine (62 citations) and Cardiology and Cardiovascular Medicine (81 citations). Pierre‐Marie Morice has collaborated with scholars based in France, United States and Spain. Frequent co-authors include Joachim Alexandre, Charles Dolladille, Laurent Poulain, Isabelle Ray‐Coquard, Kathleen N. Moore, Basile Chrétien, Eileen M. O’Reilly, Alexandra Léary, Antonio González-Martı́n and Angélique Da Silva. Their work appears in journals such as SHILAP Revista de lepidopterología, Annals of Neurology and European Heart Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.